EU-LIFE

Building and promoting Excellence in Life Sciences in Europe
Building and promoting Excellence in Life Sciences in Europe

Publications

EU-LIFE, the alliance of 13 leading Life Science Research Institutes in Europe, urges the EU Council and the European Parliament to double Horizon Europe’s budget compared to Horizon 2020 (H2020), to 150 Billion Euros and within it, to double the budget for discovery research, including the well-proven European Research Council. In addition, we strongly support the position of the President of the European Parliament, Mr. David Sassoli, on the need to include “Research” in the name of the portfolio of the EC Commissioner for Innovation and Youth.

EU-LIFE points out the increasing lack of opportunities for collaborative research in biomedicine at a European level and highlights how this is endangering long-lasting, positive impact in health research for the benefit of citizens. Based on the analysis on the barriers regarding participation in collaborative health research in Horizon 2020, 6 recommendations aim at contributing to improvement for the upcoming seven-year cycle of Horizon Europe.

EU-LIFE supports open access to scholarly publications recognising the rights of every researcher and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
We appreciate that the Plan S guidance document addresses several concerns raised by our previous statement and by other research communities. However, in answer to the two main questions regarding implementation raised during the public consultation, we believe that cOAlition S should work with diverse stakeholders to address 7 main points.

EU-LIFE supports OA to scholarly publications recognizing the rights to every scientist and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
OA implementation requires innovation and a well-thought plan engaging all different actors worldwide. Importantly, OA implementation must ensure high-level quality and fairness of the scientific publication system.
EU-LIFE puts forward 10 key recommendations on the implementation of Plan S.

On July 25th, the Court of Justice of the European Union (ECJ) ruled that organisms obtained by modern forms of mutagenesis such as CRISPR are not exempt from the EU GMO legislation. Consequently, genome edited organisms must comply with the strict conditions of the EU GMO legislation. This is in stark contrast with the opinion of the Advocate-General of the Court, which was published in January of this year and advised ruling otherwise.

 

EU-LIFE call for action on the small- and medium-sized research infrastructures

EU-LIFE urges the European Parliament and the EU Council to push for a strong Horizon Europe

Key priorities for FP9 announced in a EU-LIFE position paper

EU-LIFE institutes we urge politicians from all Members States and the European Union institutions to unequivocally support the ERC namely by increasing its budget in the next framework programme the FP9 and clearly endorsing its guiding principles of scientific merit and independence.

EU-LIFE has issued a statement on implementation aspects of H2020 as part of its contribution to the EC Public stakeholder consultation - Interim evaluation of Horizon 2020.